Tech Tour, a platform for Innovative Investors, hi-tech Entrepreneurs (from early to late stage), Corporates and Government Influencers, committed to the development of emerging technology companies from Europe, has selected Kanteron Systems among the most promising emerging digital health companies in Europe. The selection was be based on Business potential, Team experience, Product / Technology merit, and Competitive position. Taking place October 25 in Las Naves, Valencia (Spain), the Digital Health Venture Forum, organized by Tech Tour, will bring together the most promising emerging digital health companies (like Kanteron Systems), investors (from organisations like Philips, Teijin Pharma, Kreos Capital, Merck Global Health Innovation Fund, etc), and institutions (like Health 2.
Continue reading

The European Commission, through Startup Europe, has selected Kanteron Systems amongst the top 18 European scaleups (from Belgium, Czech Republic, Finland, France, Germany, Greece, Ireland, Italy, Spain, and the UK) to represent the European Union in Silicon Valley as the “next EU unicorn”. The Startup Europe initiative brings together EU policy makers (commissioners, prime ministers), the best of the new EU Scaleups and corporations to meet Silicon Valley stakeholders.
Continue reading

Kanteron Systems will participate, along with Microsoft Genomics group, in the Festival of Genomics conference to be held at Boston Convention Center (USA) June 27-29. CEO Jorge Cortell, and President & CCO John Memarian, will be demonstrating how Kanteron’s Translational Medical Information Server integrates medical images with clinical genomics, pharmacogenomics and other relevant data for the delivery of precision medicine at the point of care.
Continue reading

Author's picture

Kanteron Systems

Our blog

Precision Medicine in the Point of Care

Valencia and Madrid | New York | London